Parag Das
Overview
Explore the profile of Parag Das including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kornman C, Das P, Li L, Weldeab A, Ghiviriga I, Castellano R
J Org Chem
. 2024 Sep;
89(19):13853-13867.
PMID: 39291809
A series of oligothiophenes singly and doubly functionalized with dicyanorhodanine (RCN) units have been investigated to understand their / photoisomerization behavior upon structural modulation. Monotopic RCN target molecules (-) were...
2.
Das P, Grinalds N, Ghiviriga I, Abboud K, Dobrzycki L, Xue J, et al.
J Am Chem Soc
. 2024 Apr;
146(17):11932-11943.
PMID: 38629510
Small molecule photoswitches capable of toggling between two distinct molecular states in response to light are versatile tools to monitor biological processes, control photochemistry, and design smart materials. In this...
3.
Mungle T, Mahadevan A, Das P, Mehta A, Gogoi M, Jana B, et al.
J Pediatr Hematol Oncol
. 2023 Dec;
46(1):39-45.
PMID: 38096154
Acute lymphoblastic leukemia treatment includes an outpatient (OP)-based 2-year maintenance therapy (MT). Over an 8-year period, patients were transited from only OP to a hybrid e-clinic/OP-clinic model. Electronic and patient-held...
4.
Mungle T, Das N, Pal S, Gogoi M, Das P, Ghara N, et al.
Cancer Med
. 2023 Feb;
12(3):3499-3508.
PMID: 36812120
Background: To evaluate the treatment cost and cost effectiveness of a risk-stratified therapy to treat pediatric acute lymphoblastic leukemia (ALL) in India. Methods: The cost of total treatment duration was...
5.
Das N, Banavali S, Bakhshi S, Trehan A, Radhakrishnan V, Seth R, et al.
Trials
. 2022 Feb;
23(1):102.
PMID: 35101099
Background: In the west, survival following treatment of childhood acute lymphoblastic leukaemia (ALL) approaches 90%. Outcomes in India do not exceed 70%. To address this disparity, the Indian Collaborative Childhood...
6.
Rashan L, White A, Haulet M, Favelin N, Das P, Cock I
Evid Based Complement Alternat Med
. 2021 Jun;
2021:9918935.
PMID: 34122610
The emergence of MDR bacterial pathogens has directed antibiotic discovery research towards alternative therapies and traditional medicines. oleoresin (frankincense) was used to treat bacterial infections in traditional Arabian and Asian...